Immuron Ltd
Travelan
traveler's diarrhea
Date
TBD
Advisory committee · Date TBD estimated
What's at stake
An FDA advisory committee reviews Travelan for traveler's diarrhea around Date TBD. The panel's public vote often front-runs the agency's final verdict — and the share price.
Primary source
· SEC 6-K
verified 14h ago
“December 2025 : USU Primary Endpoint did not reach statistical significance”